Dr. Roegge has more than 15 years of industry experience in nonclinical development and safety evaluation of small molecules, biologics, and drug-device combination products. As a DABT-board certified toxicologist, Dr. Roegge has successfully led the nonclinical sections opening a number of IND/CTAs and contributing to NDA/BLA/MAAs in multiple disease areas. She also has strong current expertise in biocompatibility for long-term implanted medical devices including devices with indirect and neural contact. Prior to joining DRA, Dr. Roegge held positions at FDA’s National Center for Toxicological Research, GLP Study Director at WIL Research (currently Charles River Ashland Ohio), Project Toxicologist at Upsher Smith Laboratories and later Proximagen LLC, and most recently Senior Principal Scientist and Technical Fellow at Medtronic Neuromodulation. She holds a Ph.D. in Neuroscience from University of Illinois Urbana-Champaign with dissertation research focusing on developmental neurotoxicity of environmental contaminants, and a B.A. in Experimental Psychology and Applied Mathematics from Millikin University.